Scientists are pursuing injections or intravenous infusions of broadly neutralizing HIV antibodies (bNAbs) as a strategy for preventing HIV infection. This technique, called passive immunization, has been shown to protect monkeys from a monkey form of HIV called simian human immunodeficiency virus, or SHIV. To make passive immunization a widely feasible HIV prevention option for people, scientists want to modify bNAbs such that a modest amount of them is needed only once every few months.
S-Y Ko, et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature DOI: 10.1038/nature13612 (2014).
NIAID Director Anthony S. Fauci, M.D. and NIAID Vaccine Research Director John R. Mascola, M.D., are available for interviews.
To schedule interviews, please contact Laura S. Leifman, (301) 402-1663, email@example.com.